http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022012861-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_567af5460b63aa3f654c1a653ac1a2cb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01T1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 |
| filingDate | 2020-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75049f88815510a1335b29116eac03f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd923976797c4030be14958ff4012884 |
| publicationDate | 2022-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022012861-A |
| titleOfInvention | Compositions and Methods for Treating or Preventing Hematopoietic Disorders |
| abstract | PROBLEM TO BE SOLVED: To provide a composition for treating or preventing a hematopoietic disorder containing an orexin 2 receptor agonist as an active ingredient. In order to solve the above problems, a composition for treating or preventing a hematopoietic disorder characterized by containing an orexin 2 receptor agonist or a salt thereof as an active ingredient is provided. As an orexin 2 receptor agonist, 2- (dimethylamino) -N- [2- [3-[[5- [3- (dimethylcarbamoyl) phenyl] -2-methoxyphenyl] sulfonylamino] anilino] ethyl] Examples thereof include benzamide or a salt thereof. [Selection diagram] Fig. 1 |
| priorityDate | 2020-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.